nodes	percent_of_prediction	percent_of_DWPC	metapath
Mivacurium—CHRND—pericardium—sarcoma	0.205	0.303	CbGeAlD
Mivacurium—BCHE—diaphragm—sarcoma	0.094	0.139	CbGeAlD
Mivacurium—CHRM3—muscle of abdomen—sarcoma	0.0923	0.136	CbGeAlD
Mivacurium—CHRNA2—mammary gland—sarcoma	0.0406	0.06	CbGeAlD
Mivacurium—CHRNA1—hematopoietic system—sarcoma	0.0298	0.0441	CbGeAlD
Mivacurium—CHRND—tendon—sarcoma	0.0236	0.035	CbGeAlD
Mivacurium—CHRNA1—lymphoid tissue—sarcoma	0.021	0.031	CbGeAlD
Mivacurium—CHRNA1—tendon—sarcoma	0.0197	0.0292	CbGeAlD
Mivacurium—Hypoxia—Thiotepa—sarcoma	0.0182	0.0564	CcSEcCtD
Mivacurium—CHRNB1—tendon—sarcoma	0.0152	0.0225	CbGeAlD
Mivacurium—CHRNB1—testis—sarcoma	0.0126	0.0187	CbGeAlD
Mivacurium—CHRNB1—liver—sarcoma	0.0119	0.0176	CbGeAlD
Mivacurium—BCHE—myometrium—sarcoma	0.0114	0.0169	CbGeAlD
Mivacurium—CHRM3—smooth muscle tissue—sarcoma	0.0106	0.0157	CbGeAlD
Mivacurium—BCHE—seminal vesicle—sarcoma	0.0103	0.0153	CbGeAlD
Mivacurium—BCHE—hematopoietic system—sarcoma	0.00981	0.0145	CbGeAlD
Mivacurium—Phlebitis—Dactinomycin—sarcoma	0.00969	0.03	CcSEcCtD
Mivacurium—CHRNB1—lymph node—sarcoma	0.00915	0.0135	CbGeAlD
Mivacurium—BCHE—smooth muscle tissue—sarcoma	0.00864	0.0128	CbGeAlD
Mivacurium—BCHE—skin of body—sarcoma	0.00853	0.0126	CbGeAlD
Mivacurium—Phlebitis—Mitoxantrone—sarcoma	0.00843	0.0261	CcSEcCtD
Mivacurium—Anaphylactoid reaction—Mitoxantrone—sarcoma	0.0075	0.0232	CcSEcCtD
Mivacurium—BCHE—cardiac atrium—sarcoma	0.00745	0.011	CbGeAlD
Mivacurium—BCHE—uterus—sarcoma	0.00741	0.011	CbGeAlD
Mivacurium—Phlebitis—Etoposide—sarcoma	0.00701	0.0217	CcSEcCtD
Mivacurium—CHRM3—testis—sarcoma	0.00659	0.00974	CbGeAlD
Mivacurium—BCHE—bone marrow—sarcoma	0.00629	0.0093	CbGeAlD
Mivacurium—Anaphylactoid reaction—Etoposide—sarcoma	0.00624	0.0193	CcSEcCtD
Mivacurium—Cardiac disorder—Thiotepa—sarcoma	0.0054	0.0167	CcSEcCtD
Mivacurium—BCHE—testis—sarcoma	0.00538	0.00795	CbGeAlD
Mivacurium—Flushing—Dactinomycin—sarcoma	0.00536	0.0166	CcSEcCtD
Mivacurium—Angiopathy—Thiotepa—sarcoma	0.00528	0.0163	CcSEcCtD
Mivacurium—Immune system disorder—Thiotepa—sarcoma	0.00525	0.0162	CcSEcCtD
Mivacurium—Mediastinal disorder—Thiotepa—sarcoma	0.00524	0.0162	CcSEcCtD
Mivacurium—Arrhythmia—Thiotepa—sarcoma	0.0052	0.0161	CcSEcCtD
Mivacurium—Bronchospasm—Etoposide—sarcoma	0.00513	0.0159	CcSEcCtD
Mivacurium—Bradycardia—Mitoxantrone—sarcoma	0.00511	0.0158	CcSEcCtD
Mivacurium—BCHE—liver—sarcoma	0.00508	0.00751	CbGeAlD
Mivacurium—Erythema—Thiotepa—sarcoma	0.00506	0.0157	CcSEcCtD
Mivacurium—Erythema—Dactinomycin—sarcoma	0.00503	0.0155	CcSEcCtD
Mivacurium—Cardiac disorder—Vincristine—sarcoma	0.00479	0.0148	CcSEcCtD
Mivacurium—Angiopathy—Vincristine—sarcoma	0.00468	0.0145	CcSEcCtD
Mivacurium—Mediastinal disorder—Vincristine—sarcoma	0.00465	0.0144	CcSEcCtD
Mivacurium—Injection site reaction—Epirubicin—sarcoma	0.00464	0.0143	CcSEcCtD
Mivacurium—Arrhythmia—Mitoxantrone—sarcoma	0.00449	0.0139	CcSEcCtD
Mivacurium—Erythema—Mitoxantrone—sarcoma	0.00437	0.0135	CcSEcCtD
Mivacurium—Injection site reaction—Doxorubicin—sarcoma	0.00429	0.0133	CcSEcCtD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—sarcoma	0.00428	0.0132	CcSEcCtD
Mivacurium—Tachycardia—Thiotepa—sarcoma	0.00403	0.0125	CcSEcCtD
Mivacurium—Skin disorder—Thiotepa—sarcoma	0.00401	0.0124	CcSEcCtD
Mivacurium—Phlebitis—Epirubicin—sarcoma	0.00393	0.0122	CcSEcCtD
Mivacurium—BCHE—lymph node—sarcoma	0.0039	0.00576	CbGeAlD
Mivacurium—Cardiac disorder—Etoposide—sarcoma	0.00388	0.012	CcSEcCtD
Mivacurium—Flushing—Etoposide—sarcoma	0.00388	0.012	CcSEcCtD
Mivacurium—Angiopathy—Etoposide—sarcoma	0.00379	0.0117	CcSEcCtD
Mivacurium—Immune system disorder—Etoposide—sarcoma	0.00377	0.0117	CcSEcCtD
Mivacurium—Mediastinal disorder—Etoposide—sarcoma	0.00377	0.0116	CcSEcCtD
Mivacurium—Anaphylactic shock—Vincristine—sarcoma	0.00366	0.0113	CcSEcCtD
Mivacurium—Phlebitis—Doxorubicin—sarcoma	0.00364	0.0112	CcSEcCtD
Mivacurium—Anaphylactic shock—Mitoxantrone—sarcoma	0.00357	0.011	CcSEcCtD
Mivacurium—Anaphylactoid reaction—Epirubicin—sarcoma	0.0035	0.0108	CcSEcCtD
Mivacurium—Muscle spasms—Etoposide—sarcoma	0.0035	0.0108	CcSEcCtD
Mivacurium—Tachycardia—Mitoxantrone—sarcoma	0.00348	0.0108	CcSEcCtD
Mivacurium—Skin disorder—Mitoxantrone—sarcoma	0.00347	0.0107	CcSEcCtD
Mivacurium—Hypotension—Vincristine—sarcoma	0.00342	0.0106	CcSEcCtD
Mivacurium—Hypotension—Mitoxantrone—sarcoma	0.00333	0.0103	CcSEcCtD
Mivacurium—Urticaria—Thiotepa—sarcoma	0.00328	0.0102	CcSEcCtD
Mivacurium—Anaphylactoid reaction—Doxorubicin—sarcoma	0.00324	0.01	CcSEcCtD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.00308	0.00951	CcSEcCtD
Mivacurium—Anaphylactic shock—Etoposide—sarcoma	0.00297	0.00918	CcSEcCtD
Mivacurium—Tachycardia—Etoposide—sarcoma	0.0029	0.00896	CcSEcCtD
Mivacurium—Skin disorder—Etoposide—sarcoma	0.00288	0.00892	CcSEcCtD
Mivacurium—Urticaria—Mitoxantrone—sarcoma	0.00284	0.00877	CcSEcCtD
Mivacurium—Hypotension—Etoposide—sarcoma	0.00277	0.00858	CcSEcCtD
Mivacurium—Dizziness—Thiotepa—sarcoma	0.00273	0.00845	CcSEcCtD
Mivacurium—Rash—Thiotepa—sarcoma	0.00261	0.00806	CcSEcCtD
Mivacurium—Dermatitis—Thiotepa—sarcoma	0.0026	0.00805	CcSEcCtD
Mivacurium—Rash—Dactinomycin—sarcoma	0.00259	0.008	CcSEcCtD
Mivacurium—Dizziness—Vincristine—sarcoma	0.00242	0.00749	CcSEcCtD
Mivacurium—Bradycardia—Epirubicin—sarcoma	0.00238	0.00737	CcSEcCtD
Mivacurium—Urticaria—Etoposide—sarcoma	0.00236	0.00729	CcSEcCtD
Mivacurium—Rash—Vincristine—sarcoma	0.00231	0.00714	CcSEcCtD
Mivacurium—Dermatitis—Vincristine—sarcoma	0.00231	0.00714	CcSEcCtD
Mivacurium—Rash—Mitoxantrone—sarcoma	0.00225	0.00696	CcSEcCtD
Mivacurium—Dermatitis—Mitoxantrone—sarcoma	0.00225	0.00695	CcSEcCtD
Mivacurium—Bradycardia—Doxorubicin—sarcoma	0.00221	0.00682	CcSEcCtD
Mivacurium—Cardiac disorder—Epirubicin—sarcoma	0.00217	0.00672	CcSEcCtD
Mivacurium—Flushing—Epirubicin—sarcoma	0.00217	0.00672	CcSEcCtD
Mivacurium—Angiopathy—Epirubicin—sarcoma	0.00213	0.00657	CcSEcCtD
Mivacurium—Immune system disorder—Epirubicin—sarcoma	0.00212	0.00654	CcSEcCtD
Mivacurium—Mediastinal disorder—Epirubicin—sarcoma	0.00211	0.00653	CcSEcCtD
Mivacurium—Arrhythmia—Epirubicin—sarcoma	0.00209	0.00647	CcSEcCtD
Mivacurium—Erythema—Epirubicin—sarcoma	0.00204	0.0063	CcSEcCtD
Mivacurium—Flushing—Doxorubicin—sarcoma	0.00201	0.00622	CcSEcCtD
Mivacurium—Cardiac disorder—Doxorubicin—sarcoma	0.00201	0.00622	CcSEcCtD
Mivacurium—Angiopathy—Doxorubicin—sarcoma	0.00197	0.00608	CcSEcCtD
Mivacurium—Dizziness—Etoposide—sarcoma	0.00196	0.00607	CcSEcCtD
Mivacurium—Muscle spasms—Epirubicin—sarcoma	0.00196	0.00606	CcSEcCtD
Mivacurium—Immune system disorder—Doxorubicin—sarcoma	0.00196	0.00605	CcSEcCtD
Mivacurium—Mediastinal disorder—Doxorubicin—sarcoma	0.00195	0.00604	CcSEcCtD
Mivacurium—Arrhythmia—Doxorubicin—sarcoma	0.00194	0.00599	CcSEcCtD
Mivacurium—Erythema—Doxorubicin—sarcoma	0.00189	0.00583	CcSEcCtD
Mivacurium—Rash—Etoposide—sarcoma	0.00187	0.00579	CcSEcCtD
Mivacurium—Dermatitis—Etoposide—sarcoma	0.00187	0.00578	CcSEcCtD
Mivacurium—Muscle spasms—Doxorubicin—sarcoma	0.00181	0.00561	CcSEcCtD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.00172	0.00533	CcSEcCtD
Mivacurium—Anaphylactic shock—Epirubicin—sarcoma	0.00166	0.00515	CcSEcCtD
Mivacurium—Tachycardia—Epirubicin—sarcoma	0.00162	0.00502	CcSEcCtD
Mivacurium—Skin disorder—Epirubicin—sarcoma	0.00162	0.005	CcSEcCtD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.0016	0.00493	CcSEcCtD
Mivacurium—Hypotension—Epirubicin—sarcoma	0.00155	0.00481	CcSEcCtD
Mivacurium—Anaphylactic shock—Doxorubicin—sarcoma	0.00154	0.00476	CcSEcCtD
Mivacurium—Tachycardia—Doxorubicin—sarcoma	0.0015	0.00465	CcSEcCtD
Mivacurium—Skin disorder—Doxorubicin—sarcoma	0.0015	0.00462	CcSEcCtD
Mivacurium—Hypotension—Doxorubicin—sarcoma	0.00144	0.00445	CcSEcCtD
Mivacurium—Urticaria—Epirubicin—sarcoma	0.00132	0.00409	CcSEcCtD
Mivacurium—Urticaria—Doxorubicin—sarcoma	0.00122	0.00378	CcSEcCtD
Mivacurium—Dizziness—Epirubicin—sarcoma	0.0011	0.0034	CcSEcCtD
Mivacurium—Rash—Epirubicin—sarcoma	0.00105	0.00324	CcSEcCtD
Mivacurium—Dermatitis—Epirubicin—sarcoma	0.00105	0.00324	CcSEcCtD
Mivacurium—Dizziness—Doxorubicin—sarcoma	0.00102	0.00315	CcSEcCtD
Mivacurium—Rash—Doxorubicin—sarcoma	0.000971	0.003	CcSEcCtD
Mivacurium—Dermatitis—Doxorubicin—sarcoma	0.00097	0.003	CcSEcCtD
